In vivo evidence for a regulatory role of the kinase activity of the linotte/derailed receptor tyrosine kinase, a Drosophila Ryk ortholog

被引:10
|
作者
Taillebourg, E
Moreau-Fauvarque, C
Delaval, K
Dura, JM
机构
[1] CNRS, UPR 1142, Inst Genet Humaine, F-34396 Montpellier, France
[2] Univ Paris 06, Equipe Dev Neuronal, UMR 7102, F-75005 Paris, France
关键词
mushroom body; Drosophila; receptor tyrosine kinase; linotte/derailed; Ryk ortholog;
D O I
10.1007/s00427-004-0457-6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The RYK subfamily of receptor tyrosine kinases is characterised by unusual, but highly conserved, amino acid substitutions in the kinase domain. The linotte/derailed gene encodes a Drosophila RYK subfamily member involved in embryonic and adult central nervous system development. Previous studies have shown that the kinase activity of this receptor is not required in vivo for its embryonic function. In this study, we have investigated the role of the cytoplasmic domain and the kinase activity of the linotte/derailed receptor tyrosine kinase in adult brain development. Our results indicate that these domains are not essential for adult brain development but they are required for the proper regulation of the activity of this receptor. This sheds light on a regulatory role for the kinase activity of a RYK subfamily member.
引用
收藏
页码:158 / 163
页数:6
相关论文
共 50 条
  • [21] Role of the receptor tyrosine kinase Axl in hepatocellular carcinoma and its clinical relevance
    Niu, Zhao-Shan
    Niu, Xiao-Jun
    Wang, Wen-Hong
    FUTURE ONCOLOGY, 2019, 15 (06) : 653 - 662
  • [22] Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system
    Zhang, J
    Hughes, SE
    JOURNAL OF PATHOLOGY, 2006, 208 (04) : 453 - 461
  • [23] Recent progress on the role of axl, a receptor tyrosine kinase, in malignant transformation of myeloid leukemias
    Neubauer, A
    Burchert, A
    Maiwald, C
    Gruss, HJ
    Serke, S
    Huhn, D
    Wittig, B
    Liu, E
    LEUKEMIA & LYMPHOMA, 1997, 25 (1-2) : 91 - &
  • [24] Functions and mechanisms of receptor tyrosine kinase torso signaling:: Lessons from Drosophila embryonic terminal development
    Li, WX
    DEVELOPMENTAL DYNAMICS, 2005, 232 (03) : 656 - 672
  • [25] A Drosophila receptor-type tyrosine kinase (DFR1) acts as a fibroblast growth factor receptor in Xenopus embryos
    Yoshioka, H
    Ohuchi, H
    Ishimaru, Y
    Ishikawa, T
    Nohno, T
    Saigo, K
    Noji, S
    DEVELOPMENT GROWTH & DIFFERENTIATION, 1996, 38 (06) : 617 - 624
  • [26] Conserved regulatory motifs in the juxtamembrane domain and kinase N-lobe revealed through deep mutational scanning of the MET receptor tyrosine kinase domain
    Estevam, Gabriella O.
    Linossi, Edmond M.
    Macdonald, Christian B.
    Espinoza, Carla A.
    Michaud, Jennifer M.
    Coyote-Maestas, Willow
    Collisson, Eric A.
    Jura, Natalia
    Fraser, James S.
    ELIFE, 2024, 12
  • [27] Differential requirement for STAT by gain-of-function and wild-type receptor tyrosine kinase Torso in Drosophila
    Li, WX
    Agaisse, H
    Mathey-Prevot, B
    Perrimon, N
    DEVELOPMENT, 2002, 129 (18): : 4241 - 4248
  • [28] A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors with activity on TGFβ receptor
    Lotz-Jenne, Carina
    Luthi, Urs
    Ackerknecht, Sabine
    Lehembre, Francois
    Fink, Tobias
    Stritt, Manuel
    Wirth, Matthias
    Pavan, Simona
    Bill, Ruben
    Regenass, Urs
    Christofori, Gerhard
    Meyer-Schaller, Nathalie
    ONCOTARGET, 2016, 7 (18) : 25983 - 26002
  • [29] Role of macrophage-stimulating protein and its receptor, RON tyrosine kinase, in ciliary motility
    Sakamoto, O
    Iwama, A
    Amitani, R
    Takehara, T
    Yamaguchi, N
    Yamamoto, T
    Masuyama, K
    Yamanaka, T
    Ando, M
    Suda, T
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (04) : 701 - 709
  • [30] Pharmacological impact of FLT3 mutations on receptor activity and responsiveness to tyrosine kinase inhibitors
    Marensi, Vanessa
    Keeshan, Karen R.
    MacEwan, David J.
    BIOCHEMICAL PHARMACOLOGY, 2021, 183